Posted Sep. 6, 2013 at 10:15 a.m.

Premium Lock FDA: Lung drug from GSK and Theravance shows strong efficacy

Published: 2013-09-06 10:15:01
Updated: 2013-09-06 10:15:01

Print this blog post
Lung disease Lung disease

Studies found the once-daily inhaled therapy, called Anoro Ellipta, works against chronic obstructive pulmonary disorder, though missing data may limit the reliability of the findings, Food and Drug Administration staff said today in a report....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll